What is HumanFirst?
HumanFirst operates at the intersection of health-tech and operational logistics, providing the foundational infrastructure required to support decentralized trials and distributed care at home. The company's core value proposition lies in its ability to streamline the complex workflows associated with remote patient monitoring and data collection. By focusing on the human element of clinical research, HumanFirst aims to reduce the burden on both patients and providers, ultimately accelerating the delivery of life-saving therapies. Its market position is defined by a commitment to building robust, scalable systems that address the systemic inefficiencies inherent in legacy clinical trial frameworks.
How much funding has HumanFirst raised?
HumanFirst has raised a total of $12M across 1 funding round:
Series A
$12M
Series A (2021): $12M with participation from villageglobal.com, Lux Capital, Boost VC, Maverick Ventures, SV Angel, and Arkitekt Ventures
Key Investors in HumanFirst
Village Global
Village Global VC is an early-stage venture capital firm that supports startups with funding, mentorship, and access to a network of successful entrepreneurs and investors.
Lux Capital
Lux Capital is a New York based venture capital firm that raises dedicated funds to invest in earlystage and growthstage companies at the intersection of science and technology.
Boost VC
Boost VC is a leading investor in deep tech, focusing on emerging and frontier categories, providing funding primarily through Pre-Seed rounds and early-stage support.
What's next for HumanFirst?
With the recent influx of capital, HumanFirst is poised to expand its footprint within the digital health ecosystem. The company's strategic roadmap likely involves deepening its integration with existing clinical trial platforms and enhancing its data analytics capabilities to provide more actionable insights for pharmaceutical partners. As the industry continues to shift toward decentralized models, HumanFirst is expected to leverage its current momentum to capture a larger share of the enterprise market. Future growth will likely be driven by strategic partnerships and the continued refinement of its operational tools, ensuring that the company remains at the forefront of the transition toward more accessible and efficient healthcare delivery.
See full HumanFirst company page
